Merck Sharp & Dohme Llc NDCs and Package Codes
This page lists NDC package records associated with labeler code 67919 (Merck Sharp & Dohme Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
4
Package NDCs
3
Products
3
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
2
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| SIVEXTRO tedizolid phosphate 200 mg/4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 67919-0040-01 | — | On market | View → |
| SIVEXTRO tedizolid phosphate 200 mg/1 TABLET, FILM COATED | 67919-0041-01 | — | On market | View → |
| ZERBAXA ceftolozane and tazobactam 1 g/10mL; .5 g/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 67919-0030-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.